In Focus: M&A and Deal Making
LSX C-Suite Challenges in Life Sciences Survey 2018
In this extract from the LSX C-Suite Challenges in Life Sciences Survey 2018, we focus on senior executive respondents’ perceptions of M&As and other deal-making activities. This includes their future partnering goals, the roadblocks they come up against when seeking and establishing deals, as well as their views on what makes for a successful partnership and a sought-after partner. The LSX C-Suite Challenges in Life Sciences Survey 2018 has been designed to benchmark and give voice to the hurdles faced by C-level executives through key stages in the product and company development process.
The M&A and Deal Making report section and white paper are kindly supported by law firm CMS.
LSX (formerly Biotech and Money) is an influential community of senior life science decision makers. Through our impactful events, powerful thought leadership content and unique networking opportunities, we exist to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare.